EverSource Wealth Advisors LLC Increases Stock Holdings in Haleon plc (NYSE:HLN)

EverSource Wealth Advisors LLC raised its stake in shares of Haleon plc (NYSE:HLN) by 23.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,601 shares of the company’s stock after purchasing an additional 2,747 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Haleon were worth $139,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in HLN. Sierra Ocean LLC purchased a new position in shares of Haleon during the fourth quarter valued at about $26,000. Versant Capital Management Inc boosted its position in Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after acquiring an additional 3,348 shares in the last quarter. Geneos Wealth Management Inc. purchased a new position in shares of Haleon during the 4th quarter worth approximately $35,000. Toronto Dominion Bank raised its position in shares of Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after acquiring an additional 3,470 shares in the last quarter. Finally, Spire Wealth Management purchased a new position in shares of Haleon in the 4th quarter valued at approximately $39,000. 6.67% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HLN has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. HSBC reaffirmed a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Finally, Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Six analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $10.95.

Haleon Stock Up 1.5 %

NYSE:HLN opened at $10.31 on Tuesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The firm has a market cap of $46.65 billion, a P/E ratio of 30.31, a P/E/G ratio of 2.82 and a beta of 0.25. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a 50-day simple moving average of $9.77 and a two-hundred day simple moving average of $9.88.

Haleon (NYSE:HLN) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Analysts predict that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Increases Dividend

The firm also recently declared a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This is an increase from Haleon’s previous — dividend of $0.05. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. Haleon’s dividend payout ratio is presently 58.97%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.